MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG

被引：49

作者：

Ohta, K

Shigemoto, K

Kubo, S

Maruyama, N

Abe, Y

Ueda, N

Ohta, M ^{[1
]}

机构：

[1] Kobe Pharmaceut Univ, Dept Clin Chem, Kobe, Hyogo 6588558, Japan

[2] Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan

[3] Ehime Univ, Sch Med, Dept Hyg, Matsuyama, Ehime 790, Japan

[4] Ehime Univ, Sch Med, Dept Pathol, Matsuyama, Ehime 790, Japan

[5] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan

来源：

NEUROLOGY | 2004年 / 62卷 / 11期

关键词：

D O I：

10.1212/01.WNL.0000129274.12702.92

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：2132 / 2133

页数：3

共 5 条

[1] Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis [J].

Evoli, A ;

Tonali, PA ;

Padua, L ;

Lo Monaco, M ;

Scuderi, F ;

Batocchi, AP ;

Marino, M ;

Bartoccioni, E .

BRAIN, 2003, 126 :2304-2311

[2] Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies [J].

Hoch, W ;

McConville, J ;

Helms, S ;

Newsom-Davis, J ;

Melms, A ;

Vincent, A .

NATURE MEDICINE, 2001, 7 (03) :365-368

[3] Clinical aspects of MuSK antibody positive seronegative MG [J].

Sanders, DB ;

El-Salem, K ;

Massey, JM ;

McConville, J ;

Vincent, A .

NEUROLOGY, 2003, 60 (12) :1978-1980

[4] Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement [J].

Scuderi, F ;

Marino, M ;

Colonna, L ;

Mannella, F ;

Evoli, A ;

Provenzano, C ;

Bartoccioni, E .

LABORATORY INVESTIGATION, 2002, 82 (09) :1139-1146

[5] Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets [J].

Vincent, A ;

Bowen, J ;

Newsom-Davis, J ;

McConville, J .

LANCET NEUROLOGY, 2003, 2 (02) :99-106

← 1 →